TERESA PARKHOUSE: Open Payments
NPI 1689042012 · LA PORTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 18 payments from 11 companies in 2025. Trend: 2023 $696 · 2024 $376 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $114 |
| Madrigal Pharmaceuticals | 1 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Novo Nordisk Inc | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Corcept Therapeutics | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Viatris Specialty LLC | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
Products named: REZDIFFRA, QULIPTA, VRAYLAR, Kerendia, Wegovy, Auvelity, Korlym, REXULTI.
Industry payments across IN — which companies pay providers there.
